Exploring the Use of TCEs for Type 1 Diabetes – Preclinical Development for a HLA-A02 Targeting TCE

Time: 3:45 pm
day: Day 1

Details:

Session Details to Be Confirmed

Speakers:

Milos Aleksic
Milos Aleksic